ACS Chemical Neuroscience

Scope & Guideline

Unraveling the Molecular Mysteries of Neural Function.

Introduction

Welcome to the ACS Chemical Neuroscience information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ACS Chemical Neuroscience, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1948-7193
PublisherAMER CHEMICAL SOC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationACS CHEM NEUROSCI / ACS Chem. Neurosci.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1155 16TH ST, NW, WASHINGTON, DC 20036

Aims and Scopes

ACS Chemical Neuroscience is dedicated to advancing the understanding of chemical processes in the nervous system, focusing on the intersection of chemistry and neuroscience. The journal publishes original research that explores the molecular mechanisms underlying neurological diseases, the development of novel therapeutic agents, and innovative methodologies for studying the brain.
  1. Neurochemical Modulation and Drug Development:
    A primary focus of the journal is the exploration of neurochemical pathways and the design of pharmacological agents aimed at modulating these pathways to treat neurological disorders such as Alzheimer's, Parkinson's, and depression.
  2. Molecular Mechanisms of Neurodegeneration:
    Research articles often delve into the molecular underpinnings of neurodegenerative diseases, investigating protein aggregation, oxidative stress, and neuroinflammation as key factors in disease progression.
  3. Innovative Therapeutic Strategies:
    The journal emphasizes the development of innovative strategies for neuroprotection and neuroregeneration, including the use of small molecules, peptides, and biologics to target specific pathways involved in neuronal health.
  4. Advanced Imaging Techniques:
    Articles frequently highlight advancements in imaging modalities, such as PET and MRI, which are crucial for understanding brain function and pathology at a molecular level.
  5. Translational Research:
    The journal promotes research that bridges the gap between laboratory discoveries and clinical applications, focusing on the therapeutic potential of new compounds and their mechanisms of action.
The field of chemical neuroscience is dynamic, with emerging themes reflecting the latest scientific advancements and societal needs. Recent publications indicate several trending and emerging scopes that are gaining attention.
  1. Neuroinflammation and Immune Modulation:
    There is a marked increase in research investigating the role of neuroinflammation in various neurological disorders, along with approaches to modulate the immune response as a therapeutic strategy.
  2. Psychedelic Compounds and Their Therapeutic Potential:
    Recent papers have highlighted the exploration of psychedelics, such as psilocybin and LSD, for their potential therapeutic effects in treating mood disorders and other neuropsychiatric conditions, indicating a resurgence of interest in this area.
  3. Artificial Intelligence and Machine Learning Applications:
    The integration of AI and machine learning in drug discovery and neuroimaging is on the rise, reflecting a trend towards computational approaches that enhance the understanding of complex neurobiological systems.
  4. Targeted Protein Degradation Technologies:
    Research on targeted protein degradation, particularly in the context of neurodegenerative diseases, is gaining momentum as a novel therapeutic strategy to eliminate toxic protein aggregates.
  5. Gut-Brain Axis Research:
    There is an increasing focus on the gut-brain axis and its implications for neurodegenerative diseases and mental health, reflecting a broader understanding of the interconnectedness of physiological systems.

Declining or Waning

While ACS Chemical Neuroscience continues to thrive in several research areas, certain themes appear to be declining in prominence based on recent publication trends. This section highlights those waning scopes.
  1. Classical Neuropharmacology:
    Research focusing solely on classical neuropharmacological agents, such as traditional antidepressants or anxiolytics, seems to be losing traction as the field shifts towards more complex, multimodal approaches to treatment.
  2. Basic Neuroanatomy Studies:
    Basic studies in neuroanatomy without a clear connection to functional implications or therapeutic applications are becoming less frequent, reflecting a shift towards more integrated and applied research.
  3. Single Target Drug Development:
    The trend towards developing single-target drugs appears to be waning, as there is a growing emphasis on multitarget approaches that address the multifaceted nature of neurological disorders.
  4. In Vitro Models with Limited Relevance:
    Research relying heavily on traditional in vitro models lacking translational relevance to human physiology is decreasing, as there is a greater demand for studies utilizing more sophisticated in vivo or organoid models.

Similar Journals

NEUROSCIENCE RESEARCH

Advancing the Frontiers of Neural Discovery
Publisher: ELSEVIER IRELAND LTDISSN: 0168-0102Frequency: 12 issues/year

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

JOURNAL OF MOLECULAR NEUROSCIENCE

Connecting Molecular Insights with Clinical Applications
Publisher: SPRINGERNATUREISSN: 0895-8696Frequency: 9 issues/year

Journal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.

Translational Neuroscience

Innovating the Future of Neurological Science.
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2081-3856Frequency: 1 issue/year

Translational Neuroscience, published by DE GRUYTER POLAND SP Z O O, is a leading open-access journal since its inception in 2015, dedicated to the multidisciplinary exploration of neurological research and its clinical applications. With an ISSN of 2081-3856 and an E-ISSN of 2081-6936, the journal serves as a crucial platform for scholars and practitioners to disseminate innovative findings and theoretical advancements in the field of neuroscience. Covering various aspects of general neuroscience, it is ranked in the Q3 quartile for 2023 and positioned at Rank #75 out of 113 in its category, reflecting its growing impact within the scientific community. The journal strives to bridge the gap between laboratory research and clinical practice, fostering collaboration among researchers, clinicians, and educators. The editorial team is committed to maintaining high publication standards that engage the audience with rigorous research while promoting a culture of open science. For those interested in the forefront of neuroscience research, Translational Neuroscience offers an invaluable resource for knowledge and innovation.

CELLULAR AND MOLECULAR NEUROBIOLOGY

Driving Progress in Cellular and Molecular Neuroscience.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0272-4340Frequency: 8 issues/year

CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.

NEUROMOLECULAR MEDICINE

Unlocking the Secrets of the Nervous System
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

BRAIN RESEARCH

Advancing the frontiers of neuroscience.
Publisher: ELSEVIERISSN: 0006-8993Frequency: 24 issues/year

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

Journal of Neuroimmune Pharmacology

Pioneering Research in Neuroimmune Pharmacology
Publisher: SPRINGERISSN: 1557-1890Frequency: 4 issues/year

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

NeuroSci

Pioneering Discoveries in Cognitive and Neurobiological Studies
Publisher: MDPIISSN: Frequency: 4 issues/year

NeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.

BMC NEUROSCIENCE

Unlocking the Mysteries of the Brain, One Study at a Time
Publisher: BMCISSN: 1471-2202Frequency: 1 issue/year

BMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.

BRAIN RESEARCH BULLETIN

Shaping the future of neuroscience through impactful research.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0361-9230Frequency: 8 issues/year

BRAIN RESEARCH BULLETIN is a leading academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the dissemination of high-quality research in the interdisciplinary field of neuroscience. Since its inception in 1976, this journal has served as a vital platform for researchers, professionals, and students interested in a broad spectrum of topics within neuroscience, making significant contributions to the understanding of brain function and its associated disorders. With a commendable impact factor and a current Scopus rank of #35 out of 113 in general neuroscience, the journal holds a Q2 quartile ranking, underscoring its relevance and influence in the academic community. BRAIN RESEARCH BULLETIN invites submissions of original articles, reviews, and brief communications, enhancing scholarly communication within this dynamic field. Although the journal is not open access, it ensures widespread reach and impact through various subscription models, allowing access to pivotal findings that pave the way for future research advancements. For researchers aiming to share impactful discoveries and insights within the neuroscience community, BRAIN RESEARCH BULLETIN remains an essential outlet.